Reference Oculomotor Ranges in Eye Tracking with NeuroClues
Explore how neuroClues calculates the reference oculomotor ranges in eye tracking, with exclusive insights into the technical details.
Have a research question to share or an article to highlight?
A piece to write about neuroscience, eye tracking or neuroClues?
Let’s connect.
Explore how neuroClues calculates the reference oculomotor ranges in eye tracking, with exclusive insights into the technical details.
Explore recent studies on how eye movements can support pharmaceutical research in diagnosing, monitoring, and developing new neurological treatments.
Your guide to navigating the SfN 2024 annual meeting As you prepare for the SfN 2024 event, we’re here to help you make the most
The newsletter of this month will emphasize the latest research about Multiple Sclerosis
The newsletter of this month will emphasize the latest research about Alzheimer’s Disease
The newsletter of this month will emphasize the latest research about Progressive Supra Nuclear Palsy (PSP) as May is PSP Awareness month
The newsletter of this month will make you discover 3 recent articles highlighting the relevance of eye tracking for Concussion, Alzheimer’s disease and Parkinson’s disease.
The newsletter of this month will emphasize the latest research about Spinocerebellar Ataxia
The newsletter of this month will emphasize the latest research about Parkinson’s disease (PD) as April is Parkinson’s Awareness month
The newsletter of this month is related to the relevance of eye tracking in Alzheimer’s disease
neuroClues is powered by P3Lab SRL
VAT: BE 0750.746.841
Centre Monnet – Av. Jean Monnet, 1 –
1348 Louvain-la-Neuve – Belgium
iPeps Incubator – 187 rue Chevaleret – 75013 Paris – France
Our development is financed with
the support of the Walloon Region and the European Innovation Council
© Neuroclues 2024 – all rights reserved
Book a custom virtual walk-through of NeuroClues with one of our experts and see how our innovative eye-tracking technology could impact your clinical practice.